Sjælens Sundhedshus ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  17.9% 21.3% 16.7% 18.7% 18.7%  
Credit score (0-100)  9 5 9 7 6  
Credit rating  B B BB B B  
Credit limit (kDKK)  0.0 -0.0 0.0 -0.0 -0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  329 376 456 366 288  
EBITDA  57.2 -177 -20.5 -68.1 -52.7  
EBIT  57.2 -177 -20.5 -68.1 -52.7  
Pre-tax profit (PTP)  56.1 -180.0 -21.8 -68.9 -52.7  
Net earnings  43.3 -180.0 -21.8 -68.9 -52.7  
Pre-tax profit without non-rec. items  56.1 -180 -21.8 -68.9 -52.7  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  93.3 -86.7 -108 -177 -230  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 10.1  
Balance sheet total (assets)  208 244 183 176 69.0  

Net Debt  -142 -135 -109 -99.5 -56.9  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  329 376 456 366 288  
Gross profit growth  0.0% 14.2% 21.3% -19.7% -21.3%  
Employees  1 1 2 0 1  
Employee growth %  0.0% 0.0% 100.0% -100.0% 0.0%  
Employee expenses  0.0 0.0 0.0 -433.9 -340.4  
Balance sheet total (assets)  208 244 183 176 69  
Balance sheet change%  0.0% 17.2% -24.9% -4.1% -60.7%  
Added value  57.2 -176.7 -20.5 365.9 287.8  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  1.0 -1.0 -2.0 -3.0 -4.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  17.4% -47.0% -4.5% -18.6% -18.3%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  27.5% -65.5% -6.6% -21.1% -16.2%  
ROI %  61.3% -378.8% 0.0% 0.0% -1,044.3%  
ROE %  46.4% -106.6% -10.2% -38.4% -43.1%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  52.9% -46.4% -73.4% -82.5% -76.9%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -248.5% 76.3% 532.8% 146.1% 108.0%  
Gearing %  0.0% 0.0% 0.0% 0.0% -4.4%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.0% 0.3%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  2.5 1.3 1.2 0.8 0.2  
Current Ratio  1.8 0.7 0.6 0.5 0.2  
Cash and cash equivalent  142.2 134.9 109.1 99.5 67.0  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  93.3 -86.7 -108.4 -177.4 -230.1  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  57 -177 -10 0 288  
Employee expenses / employee  0 0 0 0 -340  
EBITDA / employee  57 -177 -10 0 -53  
EBIT / employee  57 -177 -10 0 -53  
Net earnings / employee  43 -180 -11 0 -53